Terns Pharmaceuticals Stock Price History
| TERN Stock | USD 3.35 0.21 6.69% |
If you're considering investing in Terns Stock, it is important to understand the factors that can impact its price. As of today, the current price of Terns Pharmaceuticals stands at 3.35, as last reported on the 22nd of March, with the highest price reaching 3.72 and the lowest price hitting 3.16 during the day. Terns Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.24, which indicates the firm had a -0.24 % return per unit of risk over the last 3 months. Terns Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Terns Pharmaceuticals' Risk Adjusted Performance of (0.22), coefficient of variation of (381.58), and Variance of 15.68 to confirm the risk estimate we provide.
At this time, Terns Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year. As of the 22nd of March 2025, Other Stockholder Equity is likely to grow to about 710 M, while Total Stockholder Equity is likely to drop about 153.6 M. . As of the 22nd of March 2025, Price Earnings To Growth Ratio is likely to grow to 0.44, while Price To Sales Ratio is likely to drop 142.92. Terns Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Terns |
Sharpe Ratio = -0.2403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TERN |
Estimated Market Risk
| 3.67 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.88 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Terns Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Terns Pharmaceuticals by adding Terns Pharmaceuticals to a well-diversified portfolio.
Price Book 0.7318 | Enterprise Value Ebitda (5.80) | Price Sales 302.636 | Shares Float 51.4 M | Wall Street Target Price 19.0625 |
Terns Pharmaceuticals Stock Price History Chart
There are several ways to analyze Terns Stock price data. The simplest method is using a basic Terns candlestick price chart, which shows Terns Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 23, 2024 | 5.93 |
| Lowest Price | March 20, 2025 | 3.14 |
Terns Pharmaceuticals March 22, 2025 Stock Price Synopsis
Various analyses of Terns Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Terns Stock. It can be used to describe the percentage change in the price of Terns Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Terns Stock.| Terns Pharmaceuticals Price Daily Balance Of Power | 0.37 | |
| Terns Pharmaceuticals Accumulation Distribution | 269,896 | |
| Terns Pharmaceuticals Price Action Indicator | 0.01 | |
| Terns Pharmaceuticals Price Rate Of Daily Change | 1.07 |
Terns Pharmaceuticals March 22, 2025 Stock Price Analysis
Terns Stock Price History Data
The price series of Terns Pharmaceuticals for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 3.84 with a coefficient of variation of 21.71. The price distribution for the period has arithmetic mean of 4.58. The median price for the last 90 days is 4.46. The company completed stock split (1000:50) on 4th of November 2013.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 3.16 | 3.72 | 3.16 | 3.35 | 1,792,882 | |
| 03/20/2025 | 3.12 | 3.23 | 3.09 | 3.14 | 673,036 | |
| 03/19/2025 | 3.15 | 3.25 | 3.09 | 3.16 | 591,239 | |
| 03/18/2025 | 3.18 | 3.24 | 3.13 | 3.16 | 605,138 | |
| 03/17/2025 | 3.17 | 3.30 | 3.08 | 3.25 | 1,071,559 | |
| 03/14/2025 | 3.49 | 3.50 | 3.16 | 3.18 | 1,742,784 | |
| 03/13/2025 | 3.65 | 3.70 | 3.44 | 3.45 | 812,429 | |
| 03/12/2025 | 3.50 | 3.66 | 3.45 | 3.66 | 928,262 | |
| 03/11/2025 | 3.34 | 3.52 | 3.24 | 3.48 | 1,464,139 | |
| 03/10/2025 | 3.45 | 3.58 | 3.30 | 3.36 | 840,478 | |
| 03/07/2025 | 3.60 | 3.67 | 3.48 | 3.49 | 689,081 | |
| 03/06/2025 | 3.56 | 3.67 | 3.52 | 3.63 | 669,884 | |
| 03/05/2025 | 3.51 | 3.68 | 3.49 | 3.63 | 989,734 | |
| 03/04/2025 | 3.32 | 3.54 | 3.27 | 3.51 | 909,551 | |
| 03/03/2025 | 3.72 | 3.77 | 3.31 | 3.39 | 1,420,909 | |
| 02/28/2025 | 3.57 | 3.72 | 3.54 | 3.69 | 1,277,381 | |
| 02/27/2025 | 3.76 | 3.82 | 3.68 | 3.69 | 759,999 | |
| 02/26/2025 | 3.71 | 3.89 | 3.70 | 3.76 | 565,184 | |
| 02/25/2025 | 3.80 | 3.98 | 3.65 | 3.71 | 1,123,239 | |
| 02/24/2025 | 4.00 | 4.02 | 3.72 | 3.73 | 1,295,294 | |
| 02/21/2025 | 4.19 | 4.21 | 3.96 | 4.01 | 1,038,998 | |
| 02/20/2025 | 4.18 | 4.24 | 4.08 | 4.13 | 1,630,720 | |
| 02/19/2025 | 4.11 | 4.23 | 4.01 | 4.19 | 1,067,427 | |
| 02/18/2025 | 4.11 | 4.26 | 4.11 | 4.13 | 1,083,660 | |
| 02/14/2025 | 4.09 | 4.19 | 4.03 | 4.06 | 1,050,647 | |
| 02/13/2025 | 4.36 | 4.36 | 4.07 | 4.08 | 1,384,648 | |
| 02/12/2025 | 4.23 | 4.35 | 4.20 | 4.34 | 723,650 | |
| 02/11/2025 | 4.38 | 4.44 | 4.23 | 4.30 | 1,266,195 | |
| 02/10/2025 | 4.46 | 4.52 | 4.39 | 4.46 | 2,662,650 | |
| 02/07/2025 | 4.63 | 4.76 | 4.46 | 4.48 | 695,347 | |
| 02/06/2025 | 4.67 | 4.73 | 4.56 | 4.66 | 2,094,520 | |
| 02/05/2025 | 4.54 | 4.67 | 4.44 | 4.66 | 687,156 | |
| 02/04/2025 | 4.38 | 4.55 | 4.28 | 4.52 | 1,516,293 | |
| 02/03/2025 | 4.30 | 4.47 | 4.22 | 4.37 | 1,864,844 | |
| 01/31/2025 | 4.64 | 4.75 | 4.42 | 4.46 | 2,017,305 | |
| 01/30/2025 | 4.22 | 4.72 | 4.22 | 4.64 | 3,101,989 | |
| 01/29/2025 | 4.51 | 4.64 | 4.17 | 4.18 | 3,458,975 | |
| 01/28/2025 | 4.52 | 4.58 | 4.41 | 4.46 | 2,110,539 | |
| 01/27/2025 | 4.47 | 4.73 | 4.45 | 4.53 | 2,198,344 | |
| 01/24/2025 | 4.61 | 4.66 | 4.46 | 4.50 | 1,934,630 | |
| 01/23/2025 | 4.58 | 4.76 | 4.51 | 4.64 | 1,604,791 | |
| 01/22/2025 | 4.45 | 4.81 | 4.41 | 4.67 | 1,728,959 | |
| 01/21/2025 | 4.43 | 4.66 | 4.41 | 4.45 | 2,085,741 | |
| 01/17/2025 | 4.52 | 4.62 | 4.38 | 4.43 | 1,481,423 | |
| 01/16/2025 | 4.60 | 4.64 | 4.50 | 4.50 | 1,785,137 | |
| 01/15/2025 | 4.73 | 4.87 | 4.58 | 4.63 | 1,416,071 | |
| 01/14/2025 | 4.88 | 4.90 | 4.56 | 4.57 | 1,581,533 | |
| 01/13/2025 | 4.92 | 4.93 | 4.64 | 4.80 | 1,677,577 | |
| 01/10/2025 | 5.11 | 5.16 | 4.93 | 5.01 | 1,907,213 | |
| 01/08/2025 | 5.62 | 5.62 | 5.20 | 5.25 | 1,498,362 | |
| 01/07/2025 | 5.71 | 5.86 | 5.48 | 5.63 | 2,101,676 | |
| 01/06/2025 | 5.77 | 5.95 | 5.62 | 5.71 | 1,252,282 | |
| 01/03/2025 | 5.70 | 5.80 | 5.59 | 5.75 | 1,289,224 | |
| 01/02/2025 | 5.64 | 5.77 | 5.47 | 5.67 | 1,733,145 | |
| 12/31/2024 | 5.57 | 5.65 | 5.36 | 5.54 | 1,876,134 | |
| 12/30/2024 | 5.70 | 5.75 | 5.40 | 5.53 | 1,547,997 | |
| 12/27/2024 | 5.84 | 5.95 | 5.70 | 5.77 | 967,007 | |
| 12/26/2024 | 5.74 | 5.95 | 5.65 | 5.88 | 1,661,850 | |
| 12/24/2024 | 5.93 | 5.93 | 5.69 | 5.80 | 434,435 | |
| 12/23/2024 | 5.84 | 5.98 | 5.70 | 5.93 | 1,603,343 | |
| 12/20/2024 | 5.90 | 6.13 | 5.79 | 5.86 | 4,750,011 |
About Terns Pharmaceuticals Stock history
Terns Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Terns is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Terns Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Terns Pharmaceuticals stock prices may prove useful in developing a viable investing in Terns Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 81.9 M | 86 M | |
| Net Loss | -54.3 M | -57 M |
Terns Pharmaceuticals Stock Technical Analysis
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Terns Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Terns Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Terns Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Terns to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.22) | |||
| Jensen Alpha | (0.99) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (1.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.